Clinical trial
Cardiovascular Kidney and Metaboolic (CKM) Health Assessment and Patient Empowerment in chROnic Disease Using a Health Coach INtervention ModEl: A Randomized Clinical Trial
NCT07403669 is registered in ClinicalTrials.gov with Aventyn, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Kidney and Metaboolic (CKM) Health Assessment and Patient Empowerment in chROnic Disease Using a Health Coach INtervention ModEl: A Randomized Clinical Trial
- Lead sponsor
- Aventyn, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 22, 2025
- Completion date
- April 22, 2027
- Enrollment
- 300 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
acute mi, diabetes mellitus, heart failure, kidney disease